Reactive pericytes in early phase are involved in glial activation and late-onset hypersusceptibility to pilocarpine-induced seizures in traumatic brain injury model mice.
Animals
Brain Injuries, Traumatic
/ complications
Disease Models, Animal
Disease Susceptibility
Gene Expression
Hippocampus
/ cytology
Imatinib Mesylate
/ pharmacology
Male
Mice, Inbred C57BL
Neuroglia
Pericytes
/ physiology
Pilocarpine
/ adverse effects
Receptor, Platelet-Derived Growth Factor beta
/ genetics
Seizures
/ etiology
Time Factors
Imatinib
Microglia
PDGFRβ
Reactive pericytes
Traumatic brain injury
Journal
Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
26
06
2020
revised:
27
10
2020
accepted:
20
11
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
14
5
2021
Statut:
ppublish
Résumé
In this study, among neurovascular unit (NVU) cells, we focused on pericyte reactivity in mice subjected to controlled cortical impact (CCI) to understand how traumatic brain injury (TBI) causes uncoordinated crosstalk in the NVU and alters neuronal activity. Histological analyses of brain pericytes, microglia and astrocytes were performed for up to 28 days after CCI in the injured ipsilateral hippocampus. To evaluate altered neuronal activity caused by CCI, we measured seizure susceptibility to a sub-threshold dose of pilocarpine on postoperative day 7, 14, 21 and 28. Platelet-derived growth factor receptor (PDGFR) β immunoreactivity in pericytes significantly increased from 1 h to 4 days after CCI. The expression of Iba1 and GFAP, as markers of microglia and astrocytes, respectively, increased from 4 to 28 days after CCI. The severity of seizure induced by pilocarpine gradually increased, becoming significant at 28 days after CCI. Then, we treated CCI mice with an inhibitor of PDGFR signaling, imatinib, during the postoperative day 0-4 period. Imatinib lowered seizure susceptibility to pilocarpine and suppressed microglial activation in the injured hippocampus at postoperative day 28. These findings indicate that brain pericytes with rapidly increased PDGFRβ expression may drive TBI-induced dysregulation of NVU function and brain hyperexcitability.
Identifiants
pubmed: 33357774
pii: S1347-8613(20)30114-6
doi: 10.1016/j.jphs.2020.11.008
pii:
doi:
Substances chimiques
Pilocarpine
01MI4Q9DI3
Imatinib Mesylate
8A1O1M485B
Receptor, Platelet-Derived Growth Factor beta
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-165Informations de copyright
Copyright © 2020 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no conflicts of interest to declare regarding the conduct or publication of this research.